No Data
No Data
UNI MEDICAL (02666): Lin Chunhai has been appointed as a non-executive Director.
UNI MEDICAL (02666) announced that the company received a resignation letter submitted by Xu Ming, stating that Xu Ming has reached retirement...
UNI MEDICAL (02666) subsidiary plans to issue company bonds not exceeding 1 billion yuan.
UNI MEDICAL (02666) announced that its wholly-owned subsidiary China Global Leasing Co., Ltd. has obtained approval from the China Securities...
UNI MEDICAL has officially formed four major Business Sectors, achieving a Net income of 2.258 billion yuan in 2024.
In 2024, UNI MEDICAL continues to delve deeply into the healthcare sector, officially establishing a new structure consisting of four major sectors: "Finance + Comprehensive Medical + Specialized Medical + Health Technology," which marks a key step in the process of creating a diversified and comprehensive healthcare industrial group. In 2024, all four major sectors achieved growth in net income, with the Health Technology sector showing outstanding performance, contributing a report revenue increase of 253.7% year-on-year and net income growth of 146.1%, becoming a major highlight of UNI MEDICAL's annual performance. On March 26, General
UNI MEDICAL (02666.HK) plans to issue medium-term notes with a total principal amount of up to 0.5 billion yuan.
On March 26, Gronghui announced that UNI MEDICAL (02666.HK) released a notice stating that its wholly-owned subsidiary, China Global Leasing Co., Ltd. (the 'Issuer'), registered with the China Interbank Market Dealers Association to issue domestic medium-term notes with a total principal amount of up to 2 billion yuan in China, with a remaining quota of 0.5 billion yuan as of the date of this announcement. The Issuer has decided to issue domestic medium-term notes for the first phase in 2025, with a total principal amount of up to 0.5 billion yuan to institutional investors in China. This note is for a period of three years with a fixed interest rate and will be finalized through a book-building process at the time of subscription application.
UNI MEDICAL (02666) released its annual results, with profits attributable to ordinary shareholders amounting to 2.032 billion yuan, an increase of 0.54% year-on-year.
UNI MEDICAL (02666) announced its annual performance results for the year ending December 31, 2024, with revenue of 136.6...
《Performance》 UNI MEDICAL (02666.HK) reported a net profit of 2.032 billion yuan for the year, an increase of 0.5%. The final dividend remains at 35 Hong Kong cents.
UNI MEDICAL (02666.HK) announced its full-year results for the year ending December last year, with revenue of 13.663 billion yuan (RMB), a slight increase of 0.1% year-on-year. Net profit was 2.032 billion yuan, an increase of 0.5% year-on-year; earnings per share were 1.07 yuan. A final dividend of 35 Hong Kong cents was declared, the same as the same period last year.